DogScan utilizes specially trained dogs to detect volatile organic compounds (VOCs) in breath samples, enabling early identification of lung cancer. This method allows for at-home testing without the need for medical appointments, improving patient outcomes through timely diagnosis.
Funding
Funding not disclosed
Founders
Product
Problem
Lung cancer often presents without symptoms in its early stages, leading to delayed diagnosis and reduced chances of successful treatment. Traditional screening methods require clinic visits and may not be accessible or convenient for all individuals.
Solution
DogScan offers an at-home lung cancer screening service that utilizes specially trained dogs to detect volatile organic compounds (VOCs) in breath samples. Customers order a test kit, collect a breath sample using a mask, and return it for analysis. The canine scent detection provides early indications of lung cancer, enabling individuals to seek timely medical evaluation and potentially improve treatment outcomes.
Target Audience
DogScan primarily targets individuals seeking early and convenient lung cancer screening, especially those who prefer at-home testing or want to complement traditional screening methods.
Features
- At-home breath sample collection kit for convenient and discreet testing
- Analysis of breath samples by certified scent detection dogs trained to identify lung cancer biomarkers
- Secure and confidential results reporting
- Free retesting in case of unclear or inconclusive results
- Partnership with the Lungenkrebszentrum Berlin-Havelhöhe (Lung Cancer Center Berlin-Havelhöhe)
- Regular performance evaluations of the scent detection dogs, requiring them to sniff over 2,500 samples